[ad_1] Editor’s Note: Get caught up in minutes with our quick round-up of today’s must-see news and expert opinion that has driven the precious metals and financial markets. Register here! (Kitco News) Shares are taking a look at a post-COVID world with the news that Pfizer and BioNTech COVID-19 vaccine …
Read More »Pfizer and Biontech vaccine, over 90% efficacy against COVID-19. EMERGENCY request. It happens in the THIRD week of NOVEMBER
[ad_1] Pharmaceutical giant Pfizer made the long-awaited announcement. The vaccine, developed by Pfizer and Biontech, in the third phase of the test, was found, after an interim analysis, more than 90% effective in preventing COVID-19 infection in participants who had not previously been infected with SARS-COV -2. The study was …
Read More »Coronavirus: Believing in conspiracies goes hand in hand with hesitation about vaccines
[ad_1] (MENAFN – The Conversation) While developing an effective vaccine probably won’t lead to the immediate end of the pandemic, it’s clear that things can’t go back to normal without one. Anything that reduces the effectiveness of a future vaccine will be a problem. This includes vaccine hesitation, when people …
Read More »Investors are betting that the vaccine stimulates the resurgence of downed stocks
[ad_1] By Tom Westbrook, Elizabeth Howcroft SYDNEY / LONDON (Reuters) – Investors expecting an upcoming COVID-19 vaccine are starting to buy banking and industrial stocks in anticipation of a strong return to consumer confidence, although many remain wary of risks in sectors ravaged by the pandemic . FILE PHOTO: A …
Read More »Investors are betting that the vaccine stimulates the resurgence of downed stocks
[ad_1] By Tom Westbrook, Elizabeth Howcroft SYDNEY / LONDON (Reuters) – Investors expecting an upcoming COVID-19 vaccine are starting to buy banking and industrial stocks in anticipation of a strong return to consumer confidence, although many remain wary of risks in sectors ravaged by the pandemic . FILE PHOTO: A …
Read More »Inserm takes stock of coronavirus reinfection
[ad_1] Reinfection with Sars-CoV-2, the source of the Covid-19 pandemic, is rare; however, according to the scientific community today, it does exist. Why do we get reinfected when others seem immune? Researchers are working to identify two sides of the same coin. Inserm and its Detox Channel take stock of …
Read More »Why is the Oxford-AstraZeneca vaccine easier to use than others currently being tested? An explanation from the doctor
[ad_1] Notice of great interest for the C.OVID developed by company AstraZeneca together with the University of Oxford. The vaccine could become available for use in late December, the pharmaceutical manufacturer’s chief executive said. The company is now awaiting approval from regulatory authorities in the drug market. The vaccine developed …
Read More »Potential Herpes Virus Vaccine Shows Promise – News
[ad_1] Immunization was developed by US scientists and could become the first for this disease, which affects approximately 4 billion people worldwide. The potential vaccine against the virus that causes herpes shows promise A vaccine against herpes development in the United States has shown good results in animal testing. The …
Read More »Covid-19 vaccine: study begins in Cali
[ad_1] November 6, 2020 – 11:55 pm 2020-11-06 Of: Editing of El País After pharmaceutical company Janssen, a subsidiary of Johnson & Johnson, gave approval to the Center for Pediatric Infectology Studies in Cali, Ceip, to apply its vaccine against Covid-19, phase clinical trials began this week. III of the …
Read More »Ferrets are given nasal sprays to successfully prevent Covid-19
[ad_1] Ferret getty Covid-19 infections are typically transmitted via respiratory droplets – in the nose or mouth. While masks and physical distance are now considered tried and true methods of blocking transmission, a new study looked at blocking the virus directly in the nose, even after it got there. Well, …
Read More »